For MedTech manufacturers eyeing the European market, regulatory hurdles can be daunting. Ardeevo, an AI-native service designed to streamline that process, has just closed a $169K pre-seed round led by Znext.
The company aims to simplify the extensive documentation required by the EU's MDR and IVDR regulations for medical device and in vitro diagnostic companies. Ardeevo's platform leverages AI drafting, validated by experts, to support medium-risk device manufacturers, particularly European startups and SMEs, and non-EU companies entering the continent.


















